Autologous transplant
Conditions
Interventions
This is a randomized, double-blind clinical trial conducted on patients who were indicated for mucogingival surgery associated with a gingival graft of identical dimensions. Two groups were included i
GT (Test Group): 25 people in whom the palatal wound of the donor area received suture and collagen sponge to ensure hemostasis, and will be protected with flow resin. The surgical procedure was perfo
Sponsors
Universidade Federal da ParaÍba
Universidade Federal da ParaÍba
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Participants aged 18 years or older; both genders; indicated for mucogingival surgery associated with gingival grafting; systemically healthy; with plaque index and gingival index =20%; and with a palate free of pathology or morphological alterations
Exclusion criteria
Exclusion criteria: Patients with systemic health issues that contraindicate surgery (e.g., diabetes, decompensated cardiovascular disease, chronic kidney disease) or coagulation disorders (e.g., hemophilia A/B, von Willebrand disease, anticoagulant therapy). Those who are taking medication that may potentially interfere with the healing process (e.g., continuous use of steroidal anti-inflammatory drugs or chemotherapy). Smokers. Pregnant or breastfeeding women. Additionally, participants could not have undergone previous periodontal surgery in the study area; present opportunistic oral lesions in the palate region; or use dental prostheses that cover the palate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that flowable resin will make the postoperative period of the free gingival graft (FGG) more comfortable in terms of pain and early healing compared to the use of a collagen sponge alone as a protective barrier for the palatal wound, as assessed by visual analog scale and postoperative photographs. The expressed results will be analyzed using inferential statistics appropriate for paired and unpaired situations, with a significance level of 5% | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactMariângela Barbosa
Universidade Federal da ParaÍba
Outcome results
None listed